Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Integrated BioPharma Inc. (INBP) had Debt to Equity Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$13.95M |
|
$0.61M |
|
$12.40M |
|
$1.55M |
|
$13.21M |
|
$0.74M |
|
$0.04M |
|
$0.78M |
|
$0.78M |
|
$0.61M |
|
$0.61M |
|
$0.61M |
|
$0.61M |
|
$0.74M |
|
$1.04M |
|
30.30M |
|
31.52M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$18.55M |
|
$1.81M |
|
$7.11M |
|
$25.66M |
|
$4.98M |
|
$0.03M |
|
$0.29M |
|
$5.27M |
|
$20.38M |
|
$20.38M |
|
$20.38M |
|
30.30M |
|
| Cash Flow Statement Financials | |
$1.47M |
|
$-0.20M |
|
$0.01M |
|
$1.68M |
|
$2.96M |
|
$1.28M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.72 |
|
-- |
|
-- |
|
0.00 |
|
|
Debt to Equity Ratio |
0.00 |
11.12% |
|
5.30% |
|
5.30% |
|
-- |
|
5.58% |
|
4.38% |
|
$1.27M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
1.23 |
|
2.75 |
|
32.78 |
|
3.00% |
|
3.00% |
|
2.38% |
|
2.99% |
|
$0.67 |
|
$0.04 |
|
$0.05 |
|